Phase
Condition
N/ATreatment
Budesonide/glycopyrrolate/formoterol fumarate
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with moderate to severe COPD and initiating BGF treatment according to thelocal prescribing guidance and as per their treating physician's recommendation
Enrolled in on-going single-arm studies
Provided consent for secondary use of data
Exclusion
Exclusion Criteria:
- Did not provide consent for secondary use of data
Study Design
Connect with a study center
Research Site
Mississauga,
CanadaSite Not Available
Research Site
Mississauga 6075357,
CanadaSite Not Available
Research Site
Hamburg,
GermanyActive - Recruiting
Research Site
Hamburg 2911298,
GermanySite Not Available
Research Site
Athens,
GreeceActive - Recruiting
Research Site
Athens 264371,
GreeceSite Not Available
Research Site
Milan,
ItalyActive - Recruiting
Research Site
Milan 3173435,
ItalySite Not Available
Research Site
Tokyo,
JapanActive - Recruiting
Research Site
Tokyo 1850147,
JapanSite Not Available
Research Site
Bucharest,
RomaniaSite Not Available
Research Site
Bucharest 683506,
RomaniaSite Not Available
Research Site
London,
United KingdomActive - Recruiting
Research Site
London 2643743,
United KingdomSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.